Arca
Skip to content
Tools
Tools

Depression

Drug research and approvals for depression: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 1,458 studies of depression are recruiting on ClinicalTrials.gov, Health Canada has authorized 69 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 1,458
  • Trials authorized in Canada: 69
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting now

Newest start dates first, of 1,458 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 9

Phase 2 5

Phase 1 or earlier 7

How its trials ended

7,138 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 1,586 whose ending is known, 52% met their primary endpoint, 11% missed it and 37% stopped early.

  • Completed, result not reported3,19745%
  • Ongoing1,52921%
  • Status unknown82612%
  • Met its primary endpoint82011%
  • Stopped: other or unclear3495%
  • Missed its primary endpoint1722%
  • Stopped: enrollment or feasibility1272%
  • Stopped: sponsor or business decision491%
  • Stopped: funding350%
  • Stopped: lack of efficacy290%
  • Stopped: safety50%

Trials authorized in Canada

The 10 newest of 69; search them all in Canada trials
Jul 22, 2026Does impaired brain insulin action underlie the shared risk of depression and diabetes and how does metformin affect it? an investigational neuroimaging and…Humalog / MetforminCentre for Addiction and Mental HealthPending
Oct 2, 2025A pilot randomized placebo-controlled trial of at home transcranial direct current stimulation and d-cycloserine augmentation in major depressionCycloserineGovernors of The University of CalgaryPending
Sep 19, 2025Combining ketamine with dialectical behavioural therapy (DBT) for suicidality in individuals with treatment resistant depression and borderline personality…Ketamine / MidazolamUniversity Health NetworkOngoing
May 20, 2025Intravenous ketamine (IVK) versus personalized accelerated intermittent theta-burst stimulation (PAITBS) for treatment-resistant depression (TRD): a pilot…KetamineSt Michaels HospitalPending
Mar 4, 2025Psilocybin-assisted therapy for treatment-resistant depression in bipolar ii disorder: a randomized controlled trialPsilocybin (PEX010)University of British ColumbiaOngoing
Feb 4, 2025Clinical trial protocol title: evaluating the role of psilocybin monitors in psilocybin therapy for treatment resistant depression: a pilot randomized clinical…Psilocybin (PEX010)Centre for Addiction and Mental HealthOngoing
Jan 24, 2025Intravenous ketamine and immersive virtual reality to treat depression (treasure trial): a pilot, randomized controlled trialKetamineSunnybrook Research InstituteOngoing
Dec 19, 2024Methohexital for treatment-resistant depression: a randomized, active placebo controlled pilot trialMethohexital/ DiphenhydramineSt. Michael's Hospital Unity Health TorontoClosed
Nov 7, 2024Phase 2, multicenter, double-blind, randomized, placebo controlled trial to assess the efficacy, safety, and tolerability of repeated doses of VLS-01 buccal…Dimethyltryptamine (VLS-01-BU)Atai Therapeutics, Inc.Ongoing
Oct 23, 2024A double-blind, randomized trial of quetiapine versus trazadone in women with postpartum depressionTrazodone / QuetiapineDr Verinder SharmaClosed

Medicines authorised in the EU

Newest first
Nov 9, 2017NyxoidNaloxoneMundipharma Corporation (Ireland) LimitedEMA ↗
not availableZurzuvaeZuranoloneBiogen Netherlands B.V.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.